3.73 CheckMate 577: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

OncologyMedicineHealth Policy
Written By Kerrington .

On today's episode, we have a short monologue for you on the recent CheckMate 577 study that was recently published in the New England Journal of Medicine. The title of the paper is "Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction

Kerrington .
Previous

3.74 Artificial Intelligence in Dermatology with Dr. Roxana Daneshjou
Next

3.72 Industry Payments to US Physicians for Cancer Therapeutics with Dr. Daniel Meyers